These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 16787502)

  • 1. Ringed sideroblasts with thrombocytosis: an uncommon mixed myelodysplastic/myeloproliferative disease in older adults.
    Bain B
    Br J Haematol; 2006 Aug; 134(3):340; author reply 340-1. PubMed ID: 16787502
    [No Abstract]   [Full Text] [Related]  

  • 2. Ringed sideroblasts with thrombocytosis: an uncommon mixed myelodysplastic/myeloproliferative disease of older adults.
    Shaw GR
    Br J Haematol; 2005 Oct; 131(2):180-4. PubMed ID: 16197447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Occurrence of the JAK2 V617F mutation in the WHO provisional entity: myelodysplastic/myeloproliferative disease, unclassifiable-refractory anemia with ringed sideroblasts associated with marked thrombocytosis.
    Remacha AF; Nomdedéu JF; Puget G; Estivill C; Sarda MP; Canals C; Aventin A
    Haematologica; 2006 May; 91(5):719-20. PubMed ID: 16670082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Refractory anaemia with ringed sideroblasts (RARS) associated with marked thrombocytosis: a provisional entity in the WHO classification of haematological malignancies].
    Gérard J; Dubois-Galopin F; Gardembas-Pain M; Defaux JB; Schmidt-Tanguy A; Godon A; Geneviève F; Blanchet O; Ifrah N; Zandecki M
    Ann Biol Clin (Paris); 2005; 63(6):653-9. PubMed ID: 16330386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic interaction between thrombocytosis and JAK2 V617F mutation in the WHO subcategories of myelodysplastic/myeloproliferative disease-unclassifiable and refractory anemia with ringed sideroblasts and marked thrombocytosis.
    Atallah E; Nussenzveig R; Yin CC; Bueso-Ramos C; Tam C; Manshouri T; Pierce S; Kantarjian H; Verstovsek S
    Leukemia; 2008 Jun; 22(6):1295-8. PubMed ID: 18059483
    [No Abstract]   [Full Text] [Related]  

  • 6. Essential thrombocythemia with ringed sideroblasts: a heterogeneous spectrum of diseases, but not a distinct entity.
    Schmitt-Graeff A; Thiele J; Zuk I; Kvasnicka HM
    Haematologica; 2002 Apr; 87(4):392-9. PubMed ID: 11940483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombocytosis with sideroblastic erythropoiesis: a mixed myeloproliferative myelodysplastic syndrome.
    Gupta R; Abdalla SH; Bain BJ
    Leuk Lymphoma; 1999 Aug; 34(5-6):615-9. PubMed ID: 10492088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A retrospective analysis of myelodysplastic syndromes with thrombocytosis: reclassification of the cases by WHO proposals.
    Cabello AI; Collado R; Ruiz MA; Martínez J; Navarro I; Ferrer R; Sosa AM; Carbonell F
    Leuk Res; 2005 Apr; 29(4):365-70. PubMed ID: 15725469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Refractory anemia with ringed sideroblasts and chronic myelomonocytic leukemia: myelodysplastic/myeloproliferative disease.
    D'Angelo G
    Lab Hematol; 2005; 11(3):171-3. PubMed ID: 16174602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High frequency of the JAK2 V617F mutation in patients with thrombocytosis (platelet count>600x109/L) and ringed sideroblasts more than 15% considered as MDS/MPD, unclassifiable.
    Gattermann N; Billiet J; Kronenwett R; Zipperer E; Germing U; Nollet F; Criel A; Selleslag D
    Blood; 2007 Feb; 109(3):1334-5. PubMed ID: 17244688
    [No Abstract]   [Full Text] [Related]  

  • 11. Pyoderma gangrenosum and myelodysplastic syndrome.
    Litvak D; Kirsner RS; Pakdaman NN; Federman DG
    South Med J; 2000 Sep; 93(9):923-5. PubMed ID: 11005358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis and classification of myelodysplastic syndrome: International Working Group on Morphology of myelodysplastic syndrome (IWGM-MDS) consensus proposals for the definition and enumeration of myeloblasts and ring sideroblasts.
    Mufti GJ; Bennett JM; Goasguen J; Bain BJ; Baumann I; Brunning R; Cazzola M; Fenaux P; Germing U; Hellström-Lindberg E; Jinnai I; Manabe A; Matsuda A; Niemeyer CM; Sanz G; Tomonaga M; Vallespi T; Yoshimi A;
    Haematologica; 2008 Nov; 93(11):1712-7. PubMed ID: 18838480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sideroblastic anaemia with reactive thrombocytosis versus myelodysplastic/myeloproliferative disease.
    Pérez Sánchez I; Pérez Corrala A; Menarguez Palanca J; Mayayo Crespo M; Escudero Soto A; Pintado Cros T
    Leuk Lymphoma; 2003 Mar; 44(3):557-9. PubMed ID: 12688334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diagnosis in the myelodysplastic syndrome].
    Hunstein W; Ho AD
    Dtsch Med Wochenschr; 1987 Jan; 112(2):60-2. PubMed ID: 3542464
    [No Abstract]   [Full Text] [Related]  

  • 15. Myelodysplastic syndromes: prognostic significance of multilineage dysplasia in patients with refractory anemia or refractory anemia with ringed sideroblasts.
    Dunkley SM; Manoharan A; Kwan YL
    Blood; 2002 May; 99(10):3870-1; author reply 3871. PubMed ID: 12014369
    [No Abstract]   [Full Text] [Related]  

  • 16. Prospective validation of the WHO proposals for the classification of myelodysplastic syndromes.
    Germing U; Strupp C; Kuendgen A; Isa S; Knipp S; Hildebrandt B; Giagounidis A; Aul C; Gattermann N; Haas R
    Haematologica; 2006 Dec; 91(12):1596-604. PubMed ID: 17145595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Refractory anemia.
    Uchino H
    Nihon Ketsueki Gakkai Zasshi; 1986 Dec; 49(8):1536-45. PubMed ID: 3551437
    [No Abstract]   [Full Text] [Related]  

  • 18. Luspatercept for myelodysplastic syndromes/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis.
    Komrokji RS; Platzbecker U; Fenaux P; Zeidan AM; Garcia-Manero G; Mufti GJ; Santini V; Díez-Campelo M; Finelli C; Jurcic JG; Greenberg PL; Sekeres MA; DeZern AE; Savona MR; Shetty JK; Ito R; Zhang G; Ha X; Backstrom JT; Verma A
    Leukemia; 2022 May; 36(5):1432-1435. PubMed ID: 35220402
    [No Abstract]   [Full Text] [Related]  

  • 19. Hemochromatosis-associated gene mutations in patients with myelodysplastic syndromes with refractory anemia with ringed sideroblasts.
    Nearman ZP; Szpurka H; Serio B; Warshawksy I; Theil K; Lichtin A; Sekeres MA; Maciejewski JP
    Am J Hematol; 2007 Dec; 82(12):1076-9. PubMed ID: 17654685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet count is an IPSS-independent risk factor predicting survival in refractory anaemia with ringed sideroblasts.
    Palmer SR; Tefferi A; Hanson CA; Steensma DP
    Br J Haematol; 2008 Mar; 140(6):722-5. PubMed ID: 18241255
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.